[Skin, wrinkles and botulinum toxin]. 2003

P J Nicolau, and M Chaouat, and M Mimoun
Service de chirurgie plastique, reconstructrice et esthétique et des brûlés, hôpital Rothschild, 33, boulevard de Picpus, 75571 Paris cedex 12, France. pjnicolau@mageos.com

OBJECTIVE To present an up-to-date analysis about the use of botulinum toxin for treating facial lines and wrinkles.Method. - A systematic search of the literature was conducted to select the most recent or relevant publications on this topic, through Medline. RESULTS Out of the 583 articles retrieved, 90 were finally selected for the study. CONCLUSIONS Validity of using botulinum toxin for cosmetic use is demonstrated, together with contra-indications and different methods to objectivate the results. The different available types of toxin are presented and compared. Modalities of preparation, conservation, and waste disposal are detailed. Anatomical bases of muscular facial balance are reviewed, with techniques of injection presented for each site, and also with adjunctive procedures. Complications and side effects are described and analysed. Most complications can be prevented through: perfect knowledge of local anatomy;use of small volumes;orientation of the needle bevel towards the muscle body, injection within the muscle body if thick, more superficial if thin;application of ice on the skin pre- and post-injecting. Adding epinephrin or diluting with xylocaïne and epinephrin is not commonly used. CONCLUSIONS Botulinum toxin has found its way as a major component of the therapeutic armamentarium. Its efficacy for facial rejuvenation has made it extremely popular, but its use does follow strict rules, and should be restricted to soundly trained practitioners.

UI MeSH Term Description Entries
D007273 Injections, Intramuscular Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it. Intramuscular Injections,Injection, Intramuscular,Intramuscular Injection
D001905 Botulinum Toxins Toxic proteins produced from the species CLOSTRIDIUM BOTULINUM. The toxins are synthesized as a single peptide chain which is processed into a mature protein consisting of a heavy chain and light chain joined via a disulfide bond. The botulinum toxin light chain is a zinc-dependent protease which is released from the heavy chain upon ENDOCYTOSIS into PRESYNAPTIC NERVE ENDINGS. Once inside the cell the botulinum toxin light chain cleaves specific SNARE proteins which are essential for secretion of ACETYLCHOLINE by SYNAPTIC VESICLES. This inhibition of acetylcholine release results in muscular PARALYSIS. Botulin,Botulinum Neurotoxin,Botulinum Neurotoxins,Clostridium botulinum Toxins,Botulinum Toxin,Neurotoxin, Botulinum,Neurotoxins, Botulinum,Toxin, Botulinum,Toxins, Botulinum,Toxins, Clostridium botulinum
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005145 Face The anterior portion of the head that includes the skin, muscles, and structures of the forehead, eyes, nose, mouth, cheeks, and jaw. Faces
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015595 Skin Aging The process of aging due to changes in the structure and elasticity of the skin over time. It may be a part of physiological aging or it may be due to the effects of ultraviolet radiation, usually through exposure to sunlight. Photoaging of Skin,Skin Wrinkling,Solar Aging of Skin,Aging, Skin,Skin Wrinklings,Wrinkling, Skin
D018726 Anti-Dyskinesia Agents Drugs used in the treatment of movement disorders. Most of these act centrally on dopaminergic or cholinergic systems. Among the most important clinically are those used for the treatment of Parkinson disease (ANTIPARKINSON AGENTS) and those for the tardive dyskinesias. Movement Disorder Agents,Agents, Anti-Dyskinesia,Agents, Movement Disorder,Anti Dyskinesia Agents,Disorder Agents, Movement

Related Publications

P J Nicolau, and M Chaouat, and M Mimoun
June 2010, Clinical and experimental dermatology,
P J Nicolau, and M Chaouat, and M Mimoun
September 2007, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft,
P J Nicolau, and M Chaouat, and M Mimoun
August 2014, American family physician,
P J Nicolau, and M Chaouat, and M Mimoun
March 2005, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.],
P J Nicolau, and M Chaouat, and M Mimoun
July 2021, The Cochrane database of systematic reviews,
P J Nicolau, and M Chaouat, and M Mimoun
December 2005, Journal of cosmetic dermatology,
P J Nicolau, and M Chaouat, and M Mimoun
June 2006, Journal of cosmetic dermatology,
P J Nicolau, and M Chaouat, and M Mimoun
November 1998, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.],
P J Nicolau, and M Chaouat, and M Mimoun
October 1998, Annales de chirurgie plastique et esthetique,
P J Nicolau, and M Chaouat, and M Mimoun
March 2000, Journal of the European Academy of Dermatology and Venereology : JEADV,
Copied contents to your clipboard!